James Aloysius Brady serves as Executive at Verona Pharma plc, where they oversee executive responsibilities. Since joining the company, James Aloysius Brady has executed 5 insider transactions totaling $10.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 7, 2025 involved exercising options for 72,000 shares valued at $0.
James Aloysius Brady currently holds 72,000 shares of Verona Pharma plc (VRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Aloysius Brady has been a net seller of VRNA stock. They have purchased $0 and sold $10.8K worth of shares.
James Aloysius Brady's most recent insider trade was on Oct 7, 2025, when they sold 72,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 7, 2025 | VRNA | $0 | Disposition | 23,176 | $N/A | Discretionary |
| Aug 1, 2025 | VRNA | $10.8K | Sale | 824 | $13.14 | Discretionary |
| Aug 1, 2025 | VRNA | $0 | Option Exercise | 24,000 | $N/A | Discretionary |